India proposes immediate suspension of drug manufacturing licences
In short
India has proposed an immediate suspension of drug manufacturing licences when quality problems are found. The reported goal is to stop substandard medicines from staying in the market while companies fix the issues.
This could matter for drug makers, regulators, and patients if the changes are adopted.
What the reporting says
India proposed immediate suspension of drug manufacturing licences over quality failures, according to publisher summaries of the proposed changes. The reported aim is to keep substandard medicines out of circulation while manufacturers address quality and regulatory concerns.
Why it matters
India proposed immediate suspension of drug manufacturing licences over quality failures, based on publisher summaries of the proposed changes. The reported purpose is to prevent substandard medicines from remaining in circulation while manufacturers address quality and regulatory concerns.